Cannabinoids and GI Disorders: Endogenous and Exogenous

被引:0
|
作者
Zachary Wilmer Reichenbach
Ron Schey
机构
[1] Temple University,Center for Substance Abuse Research (CSAR), Lewis Katz School of Medicine
[2] Temple University,Section of Gastroenterology, Department of Medicine, Lewis Katz School of Medicine
关键词
Cannabinoids; CB1 receptor; CB2 receptor; GPR55; Irritable bowel syndrome (IBS); GI motility; Visceral hypersensitivity;
D O I
10.1007/s11938-016-0111-1
中图分类号
学科分类号
摘要
Despite the political and social controversy affiliated with it, the medical community must come to the realization that cannabinoids exist as a ubiquitous signaling system in many organ systems. Our understanding of cannabinoids and how they relate not only to homeostasis but also in disease states must be furthered through research, both clinically and in the laboratory. The identification of the cannabinoid receptors in the early 1990s have provided us with the perfect target of translational research. Already, much has been done with cannabinoids and the nervous system. Here, we explore the implications it has for the gastrointestinal tract. Most therapeutics currently on the market presently target only one aspect of the cannabinoid system. Our main purpose here is to highlight areas of research and potential avenues of discovery that the cannabinoid system has yet to reveal.
引用
收藏
页码:461 / 477
页数:16
相关论文
共 50 条
  • [41] Control of pain initiation by endogenous cannabinoids
    Antonio Calignano
    Giovanna La Rana
    Andrea Giuffrida
    Daniele Piomelli
    Nature, 1998, 394 : 277 - 281
  • [42] Control of pain initiation by endogenous cannabinoids
    Calignano, A
    La Rana, G
    Giuffrida, A
    Piomelli, D
    NATURE, 1998, 394 (6690) : 277 - 281
  • [43] Cannabinoids, endogenous ligands and synthetic analogs
    Pop, E
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) : 418 - 425
  • [44] Endogenous cannabinoids and cardiac dysfunction in cirrhosis
    Ippolito, S.
    Mani, A. R.
    Moore, K. P.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S77 - S77
  • [45] Endogenous Cannabinoids in Crohn's Disease
    Bochenek, Michal S.
    Tomasik, Jan T.
    Wedrychowicz, Andrzej
    Tomasik, Przemyslaw J.
    APPLIED SCIENCES-BASEL, 2024, 14 (15):
  • [46] Endogenous cannabinoids revisited: A biochemistry perspective
    Fonseca, B. M.
    Costa, M. A.
    Almada, M.
    Correia-da-Silva, G.
    Teixeira, N. A.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 102 : 13 - 30
  • [47] Endogenous cannabinoids: retrograde synaptic messengers
    不详
    NEUROSCIENTIST, 2001, 7 (05): : 354 - 354
  • [48] Endogenous cannabinoids: Their discovery and future perspectives
    Mechoulam, R
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 528P : 8S - 9S
  • [49] Endogenous and exogenous commitment
    Breig, Zachary
    ECONOMICS LETTERS, 2019, 183
  • [50] ENDOGENOUS AND EXOGENOUS THROMBOLYSIS
    DEUTSCH, E
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1971, : 145 - &